Literature DB >> 21501212

Neurotoxic effects associated with antibiotic use: management considerations.

Marie F Grill1, Rama K Maganti.   

Abstract

The clinical manifestations of antibiotic-induced neurotoxic effects, the underlying mechanisms and management strategies have been reviewed. PubMed and OVID searches (January 1960-June 2010) were conducted using search terms such as antibiotics, side effects, neurotoxicity and encephalopathy which yielded approximately 300 articles. All relevant case reports, case series, letters and retrospective reviews describing neurotoxic effects and those discussing mechanisms of neurotoxicity were included. Antibiotic-induced neurotoxic side effects can have a myriad of neurologic presentations. Patients with prior central nervous system (CNS) disease, renal insufficiency and advanced age may be particularly vulnerable. Treatment consists of discontinuation of the offending agent, use of antiepileptic drugs in the case of seizures or status epilepticus and haemodialysis in certain cases. The risk of CNS toxicity may be reduced via dosage adjustments in high risk populations. Awareness of the potential neurotoxic clinical manifestations of various antibiotics and high degree of vigilance in critically ill patients is essential in identifying a potentially serious, though reversible complications of antibiotic therapy particularly with the advent of newer antimicrobial agents.
© 2011 The Authors. British Journal of Clinical Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21501212      PMCID: PMC3175508          DOI: 10.1111/j.1365-2125.2011.03991.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  126 in total

1.  Interaction of neuromuscular blocking effects of neomycin and polymyxin B.

Authors:  C Lee; A J de Silva
Journal:  Anesthesiology       Date:  1979-03       Impact factor: 7.892

2.  Safety of ofloxacin--adverse drug reactions reported during phase-II studies in Europe and in Japan.

Authors:  R Blomer; K Bruch; H Krauss; W Wacheck
Journal:  Infection       Date:  1986       Impact factor: 3.553

Review 3.  The neurotoxicity of antibacterial agents.

Authors:  S R Snavely; G R Hodges
Journal:  Ann Intern Med       Date:  1984-07       Impact factor: 25.391

4.  Tobramycin and neuromuscular blockade.

Authors:  T A Boliston; R Ashman
Journal:  Anaesthesia       Date:  1978-06       Impact factor: 6.955

5.  A possible hazard of prolonged neuromuscular blockade by amikacin.

Authors:  Y Hashimoto; T Shima; S Matsukawa; M Satou
Journal:  Anesthesiology       Date:  1978-09       Impact factor: 7.892

6.  Neurologic toxicity associated with high-dose metronidazole therapy.

Authors:  S Frytak; C H Moertel; D S Childs
Journal:  Ann Intern Med       Date:  1978-03       Impact factor: 25.391

Review 7.  Nitrofurantoin.

Authors:  P F D'Arcy
Journal:  Drug Intell Clin Pharm       Date:  1985 Jul-Aug

8.  Neuromuscular blocking activity of aminoglycoside antibiotics.

Authors:  A G Paradelis; C Triantaphyllidis; M M Giala
Journal:  Methods Find Exp Clin Pharmacol       Date:  1980-02

9.  Neurotoxicity of intrathecal gentamicin: a case report and experimental study.

Authors:  I Watanabe; G R Hodges; D L Dworzack; J J Kepes; G F Duensing
Journal:  Ann Neurol       Date:  1978-12       Impact factor: 10.422

10.  Effects of the aminoglycoside antibiotics, streptomycin and neomycin, on neuromuscular transmission. II. Postsynaptic considerations.

Authors:  J F Fiekers
Journal:  J Pharmacol Exp Ther       Date:  1983-06       Impact factor: 4.030

View more
  78 in total

1.  Antibiotic-induced neurotoxicity.

Authors:  Shamik Bhattacharyya; Ryan Darby; Aaron L Berkowitz
Journal:  Curr Infect Dis Rep       Date:  2014-12       Impact factor: 3.725

2.  Is gentamicin affecting the neuromuscular system of critically ill patients?

Authors:  Luuk Wieske; Reinier M van Hest; Esther Witteveen; Camiel Verhamme; Marcus J Schultz; Ivo N van Schaik; Janneke Horn
Journal:  Intensive Care Med       Date:  2015-03-10       Impact factor: 17.440

Review 3.  Neuropsychiatric Effects of Antimicrobial Agents.

Authors:  Nicholas Zareifopoulos; George Panayiotakopoulos
Journal:  Clin Drug Investig       Date:  2017-05       Impact factor: 2.859

Review 4.  Infections in Neurocritical Care.

Authors:  John C O'Horo; Priya Sampathkumar
Journal:  Neurocrit Care       Date:  2017-12       Impact factor: 3.210

5.  Lesson of the month 2: An easily missed cause of confusion.

Authors:  Ben Oliveira; Sangita Chaterjee; Aine Burns
Journal:  Clin Med (Lond)       Date:  2016-10       Impact factor: 2.659

6.  Metronidazole-induced neurotoxicity presenting with sudden bilateral hearing loss, encephalopathy, and cerebellar dysfunction.

Authors:  Elmira Agah; Arman Habibi; Hamed Naderi; Abbas Tafakhori
Journal:  Eur J Clin Pharmacol       Date:  2016-10-15       Impact factor: 2.953

7.  Cotrimoxazole-Induced Tremor.

Authors:  Glen Brown
Journal:  Can J Hosp Pharm       Date:  2018-06-28

8.  Elimination of peripheral auditory pathway activation does not affect motor responses from ultrasound neuromodulation.

Authors:  Morteza Mohammadjavadi; Patrick Peiyong Ye; Anping Xia; Julian Brown; Gerald Popelka; Kim Butts Pauly
Journal:  Brain Stimul       Date:  2019-03-06       Impact factor: 8.955

9.  Seizures among long-term survivors of conservatively treated ICH patients: incidence, risk factors, and impact on functional outcome.

Authors:  Dominik Madžar; Joji B Kuramatsu; Stephanie Gollwitzer; Hannes Lücking; Stephan P Kloska; Hajo M Hamer; Martin Köhrmann; Hagen B Huttner
Journal:  Neurocrit Care       Date:  2014-10       Impact factor: 3.210

Review 10.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.